IP Library Granted Patent US 8,956,348
Granted Patent B2
US 8,956,348 · App. 13/187,332 · Granted Feb 17, 2015

Methods and systems for endometrial ablation

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,956,348
App. No.
13/187,332
Granted
Feb 17, 2015
Kind
B2
Abstract

Methods, systems and devices for endometrial ablation. In accordance with a method, a working end of an RF ablation device is positioned in a patient uterus to contact endometrial tissue, the working end comprising a dielectric wall capable of non-expanded and expanded shapes. A Hall effect sensor carried by the working end is used to generate a signal that indicates a dimension of the uterine cavity or a frame-open parameter of the working end.

Claims (47)

1. A system for treating uterine tissue, comprising:

an energy-delivery structure moveable between non-expanded and expanded shapes, the expanded shape configured for positioning in a uterine cavity;

a Hall effect sensor carried in a first peripheral portion of the structure when in the expanded shape; and

a magnet carried by a second portion of the structure when in the expanded shape, the second portion being removed from the first portion.

2. The system of claim 1 , wherein the second portion is within a central portion of the structure when in an expanded shape.

3. The system of claim 1 , wherein the second portion is within a peripheral portion of the structure when in an expanded shape.

4. The system of claim 1 including a plurality of Hall effect sensors.

5. The system of claim 1 wherein the Hall effect sensor is carried about a centerline of the structure.

6. The system of claim 1 wherein the magnet is carried about a centerline of the structure.

7. The system of claim 1 , wherein the magnet is a permanent magnet.

8. The system of claim 1 , wherein the magnet is an electromagnet.

9. The system of claim 1 , wherein the energy-delivery structure comprises a thin wall member.

10. The system of claim 1 , wherein the energy-delivery structure comprises a dielectric.

11. The system of claim 1 , wherein the energy-delivery structure comprises a frame.

12. The system of claim 1 , wherein the energy-delivery structure comprises at least one electrode.

13. The system of claim 1 , wherein the energy-delivery structure comprises bi-polar electrodes.

14. A tissue ablation system, comprising:

a thin wall expandable structure having an interior chamber; and

a Hall effect sensor and a magnet carried in first and second locations, respectively, in the interior chamber;

wherein the Hall effect sensor provides a signal of movement of the magnet away from the sensor upon expansion of the expandable structure thereby indicating an expansion parameter of the structure.

15. The system of claim 14 , wherein the expandable structure comprises a dielectric.

16. The system of claim 14 , wherein the magnet is a rare earth magnet.

17. The system of claim 14 , further comprising a gas source in fluid communication with the interior chamber.

18. The system of claim 14 , further comprising a radiofrequency source operatively coupled to at least one electrode within the interior chamber.

19. The system of claim 14 , further comprising a radiofrequency source operatively coupled to at least one electrode carried by the expandable structure.

20. A system for endometrial ablation, comprising:

a working end including an expandable-collapsible energy delivery surface configured for deployment in a patient uterus;

a Hall effect sensor adjacent the energy delivery surface; and

magnetic field means carried by the working end.

21. The system of claim 20 , further comprising an ablation energy source operatively coupled to the energy delivery surface.

22. The system of claim 20 , further comprising an ablation energy source operatively coupled to the energy delivery surface.

23. The system of claim 20 , wherein the magnetic field means comprises a magnet.

24. The system of claim 20 , wherein the magnetic field means comprises a plurality of magnets.

25. The system of claim 20 , wherein the signal indicates a volume of the uterine cavity.

26. The system of claim 20 , wherein the signal indicates width of the uterine cavity.

27. The system of claim 20 , wherein the signal indicates length of the uterine cavity.

28. The system of claim 20 , wherein the expandable-collapsible structure is expanded by an interior frame.

29. The system of claim 20 , wherein the expandable-collapsible structure is expanded by an inflation medium.

30. The system of claim 20 , further comprising actuating an energy source to delivery ablative energy from the working end to the uterine cavity.

31. The system of claim 20 , further comprising acquiring a signal from the Hall effect sensor, and utilizing the signal to select a parameter of ablative energy delivery from the working end to the uterine cavity.

32. A system for endometrial ablation, comprising:

a working end including an expandable-collapsible energy delivery surface configured for deployment in a patient uterus;

a Hall effect sensor carried by the working end configured to provide a signal relating to a uterine dimension; and

a controller having an algorithm for controlling energy applied by the energy delivery surface based on the signal.

33. A method of characterizing a uterine cavity, comprising:

transcervically introducing a device working end into a patient uterus; and

expanding an expandable-collapsible structure carrying at least one Hall effect sensor and magnet, wherein the Hall effect sensor varies its output in response to a change in the magnetic field to provide a signal indicative of a dimensional parameter of the uterine cavity.

Assignments (7)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 12, 2026
From: MINERVA SURGICAL, INC.
To: AXORA MEDICAL, INC.
Reel/Frame 075561/0186 →
RELEASE OF SECURITY INTEREST Recorded Feb 5, 2026
From: CANADIAN IMPERIAL BANK OF COMMERCE
To: MINERVA SURGICAL, INC.
Reel/Frame 074721/0585 →
SECURITY INTEREST Recorded Jan 30, 2026
From: AXORA MEDICAL, INC.
To: SYMBIOTIC CAPITAL AGENCY LLC, AS ADMINISTRATIVE AGENT AND COLLATERAL AGENT
Reel/Frame 074537/0617 →
RELEASE OF SECURITY INTEREST Recorded Oct 12, 2021
From: ARES CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
To: MINERVA SURGICAL, INC.
Reel/Frame 057770/0451 →
SECURITY INTEREST Recorded Oct 8, 2021
From: MINERVA SURGICAL, INC.
To: CANADIAN IMPERIAL BANK OF COMMERCE
Reel/Frame 057758/0137 →
SECURITY INTEREST Recorded Dec 31, 2019
From: MINERVA SURGICAL, INC.
To: ARES CAPITAL CORPORATION
Reel/Frame 051395/0275 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 10, 2011
From: BEK, ROBIN
To: MINERVA SURGICAL, INC.
Reel/Frame 027208/0649 →